Adriana Dantas

Adriana Dantas is a global biotech and medical-device leader with more than 20 years of

experience bringing breakthrough technologies from bench to bedside. A biochemist and

pharmacist turned business strategist, she has built a career at the intersection of science,

operations, and commercialization—bridging research innovation with real-world impact.

Before co-founding Xella Health, Adriana held senior executive roles at Roche, Becton

Dickinson, and Mammoth Biosciences, where she led cross-functional teams spanning R&D,

operations, and go-to-market execution. Her leadership has guided product portfolios that

achieved first- and second-in-market share positions globally, and she has lived and led across

five countries, cultivating a truly international perspective on healthcare delivery and innovation.

One of her proudest achievements was leading the women's health division at Roche, including

the acquisition and multinational rollout of the Ariosa line for non-invasive prenatal testing.

She holds an MBA from FGV (Brazil) and Cranfield School of Management (UK), and a

Doctorate in Pharmacy and Biochemistry from the University of São Paulo.